daily market
intelligence service for the diagnostics industry from the publishers of
- Daily email alerts featuring the latest diagnostic industry news
- 25 issues of Clinica Diagnostics in the user-friendly format, available as a 16-page print or PDF
- A fully searchable archive of articles dating back to January 2007
Westover leads Biophysical's blood test charge in the UK
Biophysical, a US developer of biomarker-based technologies, is set to make its much-publicised Biophysical250 test available in the UK through an exclusive licensing deal with Westover Medical. The deal, of which financial terms were not disclosed, will see UK-based private healthcare provider Westover offer the test in its two existing clinics in London and in a third to be opened in the capital later this year.
Read more...
-
2007 shows "good start" to Axis-Shield's new commercialisation phase
Anglo-Nordic IVD developer Axis-Shield said it succeeded in achieving "strong underlying growth" for 2007 in the face of a weak dollar and the continued decline in homocysteine revenues. The company posted revenues of £66.7m ($134m), up 10% from the previous year, while operating profit climbed 31% to £7.1m. Pre-tax profit was £2m.
Read more... -
UK team create "most sensitive TB test ever developed"
A new blood test developed by UK-based researchers could rule out tuberculosis (TB) infection within 48 hours, a study has shown. The study shows that use of the new test, called ELISpot-Plus, in conjunction with tuberculin skin test (the current standard), can prove that a patient does not have TB with 99% accuracy. The trial, results of which were published in the March 4 issue of Annals of Internal Medicine, was conducted by a team from Imperial College, London and the University of Oxford.
Read more... -
Japan diagnostics market set for growth
Two upcoming shifts in Japan's healthcare sector will create opportunities for US diagnostics and medical devices companies, according to the Japan External Trade Organisation (Jetro).
Read More... -
Spain misses chance to take EU lead on rare diseases screening
The Spanish government has sought to reaffirm its commitment to rare diseases, but has fallen short of taking an EU lead on the issue with a much-called-for screening strategy. The national rare diseases federation (FEDER) renewed calls for the launch of services to improve early diagnosis (including neonatal screening) and prevention, during a conference to mark the first European Rare Diseases Day, on February 29, but the government did not oblige.
Read more...
-
Latest Industry News
Gain an insider's view into the latest news on companies, regulations, product launches and recalls, scientific developments, diagnostic policy developments, senior appointments and upcoming industry events. -
Market Sector Profiles
Plan your product strategy with detailed market sector profiles on each of the following product sectors:
- Clinical Chemistry
- Diabetes testing
- Haemotology
- Immundiagnostics
- Microbiology
- Molecular diagnostics
- Point of care and home testing
Each profile contains market size data, forecasts to 2011, technological developments, end-user trends, company activity and market analysis. -
Company Profiles
Assess your key competitors and avoid the pitfalls of others using the in-depth company profiles on companies such as Abbott, Johnson & Johnson, Siemens, Olympus and Biosite.
Each company profile covers financial data, recent acquisitions, major milestones and new products.